REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
03/07/2026
Back to search
Official data from USPTO
GEMS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
03/08/2026
Trademark type
Combined
Nice classes
1, 5
Filing date
11/20/2015
Registration date
01/03/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/09/2023
Last transaction
03/08/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
5
Owner type
16
Owner location
Sydney NSW, AU
Examiner
BRODY, DANIEL S
Law office
M60
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Genea IP Holdings Pty Ltd
Genea IP Holdings Pty Ltd
Genea Limited
Representatives
Eric Lamb Frost Brown Todd LLP
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Cell culture media other than for medical or veterinary usefor laboratory use in relation to researchingdiagnosing and/or treating infertility and other disorders relating to fertility and reproduction and in relation to researching and/or undertaking cell fertilizationdivision and cultivation; cell culture media other than for medical or veterinary usefor scientific and research use in relation to researchingdiagnosing and/or treating infertility and other disorders relating to fertility and reproduction and in relation to researching and/or undertaking cell fertilizationdivision and cultivation; human cell productspluripotent and differentiated human cells and stem cells for research or scientific purposes; human cell productspluripotent and differentiated human cells and stem cells for laboratory use excluding medical and veterinary use; biological and chemical products and substances for scientific use other than for medical or veterinary usechemicals for use in science in relation to researchingdiagnosing and/or treating infertility and other disorders relating to fertility and reproduction and in relation to researching and/or undertaking cell fertilizationdivision and cultivationchemical preparations for scientific purposes in relation to researchingdiagnosing and/or treating infertility and other disorders relating to fertility and reproduction and in relation to researching and/or undertaking cell fertilizationdivision and cultivationbiological preparations to support growth of human cellshuman embryoshuman reproductive tissuehuman spermhuman blastocysts or human oocyteschemical preparations to support growth of human cellshuman embryoshuman reproductive tissuehuman spermhuman blastocysts or human oocyteschemical reagents for scientific use in relation to researchingdiagnosing and/or treating fertility and other disorders relating to fertility and reproduction and in relation to researching and/or undertaking cell fertilizationdivision and cultivation
Class 5
Culture media for medical use for use to support growth of human cellshuman embryoshuman reproductive tissuehuman spermhuman blastocysts or human oocytes for medical purposes; cell culture media for medical use for use to support growth of human cellshuman embryoshuman reproductive tissuehuman spermhuman blastocysts or human oocytes for medical purposes; human cell productspluripotent and differentiated human cells and stem cells for medical or clinical use; cell culture media for use in medical or medical research applications for cultivating human cellshuman embryoshuman reproductive tissuehuman spermhuman blastocysts or human oocytes; biological and chemical products and substances for medical usechemicals for medical or clinical use in relation to assisted reproductive therapiescell fertilizationcell division and cell cultivation and diagnosing and/or treating fertility and other disorders relating to fertility and reproductionchemical preparations for medical or clinical use in relation to assisted reproductive therapiescell fertilizationcell division and cell cultivation and diagnosing and/or treating fertility and other disorders relating to fertility and human reproductionchemical preparations for the treatment of infertility and other disorders relating to fertility and human reproductionbiological preparations for the treatment of infertility and other disorders relating to fertility and human reproductionbiological preparations to support growth of human cellshuman embryoshuman reproductive tissuehuman spermhuman blastocysts or human oocyteschemical preparations to support growth of human cellshuman embryoshuman reproductive tissuehuman spermhuman blastocysts or human oocyteschemical reagents for medical use in relation to assisted reproductive therapiescell fertilizationcell division and cell cultivation and diagnosing and/or treating fertility and other disorders relating to fertility and reproduction; pharmaceutical preparations for the treatment of infertility and other disorders relating to fertility and human reproduction
Publications
History of USPTO decisions and trademark events.
40 publications found
RNWL
INTERNATIONAL REGISTRATION RENEWED
12/11/2025
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
09/09/2023
71AG
REGISTERED-SEC.71 ACCEPTED
09/09/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/08/2023
ES71
TEAS SECTION 71 RECEIVED
02/20/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/07/2022
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
01/03/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/15/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/18/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/18/2019
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/22/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/04/2017
FIMP
FINAL DISPOSITION PROCESSED
04/04/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/03/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
01/03/2017
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/02/2016
DOCK
ASSIGNED TO EXAMINER
11/15/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/18/2016
PUBO
PUBLISHED FOR OPPOSITION
10/18/2016
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/28/2016
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/28/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/28/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/14/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/09/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/02/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/02/2016
ALIE
ASSIGNED TO LIE
09/02/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/29/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/25/2016
CHLD
CHANGE OF OWNER RECEIVED FROM IB
07/01/2016
RFNT
REFUSAL PROCESSED BY IB
03/19/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/01/2016
RFRR
REFUSAL PROCESSED BY MPU
03/01/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/01/2016
CNRT
NON-FINAL ACTION WRITTEN
02/29/2016
DOCK
ASSIGNED TO EXAMINER
02/24/2016
MAFR
APPLICATION FILING RECEIPT MAILED
01/09/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/05/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/03/2016
Continuous trademark protection
Get notified about every new filing that threatens GEMS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.